These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 4276489)
1. Development of modern components of the mechanism of cardiac hypertrophy. Meerson FZ Circ Res; 1974 Aug; 35(2):suppl II:58-63. PubMed ID: 4276489 [No Abstract] [Full Text] [Related]
2. Heterogeneity of contractile function in cardiac hypertrophy. Skelton CL; Sonnenblick EH Circ Res; 1974 Aug; 35(2):suppl II:83-96. PubMed ID: 4276492 [No Abstract] [Full Text] [Related]
3. Some biochemical lesions in myocardial disease. Sordahl LA Tex Rep Biol Med; 1979; 38():121-35. PubMed ID: 161081 [No Abstract] [Full Text] [Related]
4. The myocardium in hyperfunction, hypertrophy and heart failure. Meerson FZ Circ Res; 1969 Jul; 25(1):Suppl 2:1-163. PubMed ID: 4240407 [No Abstract] [Full Text] [Related]
5. Biochemical studies concerning etiology of hypertrophy, heart failure, and cardiomyopathy. Schwartz A Recent Adv Stud Cardiac Struct Metab; 1973; 2():501-2. PubMed ID: 4283354 [No Abstract] [Full Text] [Related]
6. [A new disease model: hereditary non-vascular myocardial degeneration with heart failure]. Bajusz E; Lossnitzer K Munch Med Wochenschr; 1968 Aug; 110(31):1756-68. PubMed ID: 5755400 [No Abstract] [Full Text] [Related]
15. Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts. Tatsumi T; Akashi K; Keira N; Matoba S; Mano A; Shiraishi J; Yamanaka S; Kobara M; Hibino N; Hosokawa S; Asayama J; Fushiki S; Fliss H; Nakagawa M; Matsubara H J Mol Cell Cardiol; 2004 Sep; 37(3):775-84. PubMed ID: 15350850 [TBL] [Abstract][Full Text] [Related]
16. [Dynamics of nucleic acid and protein synthesis in the myocardium during compensatory hyperfunction and cardiac hypertrophy]. Meerson FZ; Alekhina GM; Aleksandrov PN; Bazardzhan AG Kardiologiia; 1967 May; 7(5):3-12. PubMed ID: 4238582 [No Abstract] [Full Text] [Related]
17. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy. Bello Roufai M; Li H; Sun Z Gene Ther; 2007 Oct; 14(19):1406-16. PubMed ID: 17637797 [TBL] [Abstract][Full Text] [Related]
18. Role of endocrine factors in the pathogenesis of cardiac hypertrophy. Cohen J Circ Res; 1974 Aug; 35(2):suppl II:49-57. PubMed ID: 4276488 [No Abstract] [Full Text] [Related]
19. Sensitivity to ischaemic ATP breakdown in different models of cardiac hypertrophy in rats. Harmsen E; Schoemaker R; Yu J; Ruzicka M; Leenen FH J Hypertens; 1994 Jan; 12(1):49-57. PubMed ID: 8157944 [TBL] [Abstract][Full Text] [Related]
20. Congestive and hypertrophic cardiomyopathies. A decade of study. Goodwin JF Lancet; 1970 Apr; 1(7650):732-9. PubMed ID: 4191245 [No Abstract] [Full Text] [Related] [Next] [New Search]